Title
|
|
|
|
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck: an EORTC New Drug Development Group study
| |
Author
|
|
|
|
| |
Institution/Organisation
|
|
|
|
EORTC-New Drug Development Group
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
European journal of cancer. - Oxford, 1965 - 1981
| |
Publication
|
|
|
|
Oxford
:
2004
| |
ISSN
|
|
|
|
0014-2964
[print]
1879-2995
[online]
| |
DOI
|
|
|
|
10.1016/J.EJCA.2004.08.024
10.1016/S0959-8049(04)00742-7
| |
Volume/pages
|
|
|
|
40
(2004)
, p. 2748-2752
| |
ISI
|
|
|
|
000225993400022
| |
Full text (Publisher's DOI)
|
|
|
|
| |
|